Standardization of rubella immunoassays

Parkman, 1962, Recovery of rubella virus from army recruits, Proc. Soc. Exp. Biol. Med., 111, 225, 10.3181/00379727-111-27750 Parkman, 1964, Studies of rubella. ii. neutralization of the virus, J. Immunol., 93, 608, 10.4049/jimmunol.93.4.608 Stewart, 1967, Rubella-virus hemagglutination-inhibition test, N. Engl. J. Med., 276, 554, 10.1056/NEJM196703092761006 World Health Organization, 2011, Rubella vaccines: WHO position paper, Wkly. Epidemiol. Rec., 86, 301 Haukenes, 1975, False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure, Med. Microbiol. Immunol., 161, 99, 10.1007/BF02121750 Lennette, 1967, The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status, J. Immunol., 99, 785, 10.4049/jimmunol.99.4.785 Skendzel, 1981, Current status of rubella testing: a report based on data from the College of American Pathologists’ surveys, 1978–1980, Am. J. Clin. Pathol., 76, 547 Skendzel, 1983, Evaluation of assays for the detection of antibodies to rubella. A report based on data from the College of American Pathologists Surveys of 1982, Am. J. Clin. Pathol., 80, 594 W.H.O, 1971 Clarke, 1975, The British standard for anti-rubella serum, J. Biol. Stand., 3, 151, 10.1016/0092-1157(75)90041-4 Collaborative Study, 1996, 1 Vaananen, 1985, Comparison of a simple latex agglutination test with hemolysis-in-gel, hemagglutination inhibition, and radioimmunoassay for detection of rubella virus antibodies, J. Clin. Microbiol., 21, 793, 10.1128/JCM.21.5.793-795.1985 Matter, 1997, Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations, J. Infect. Dis., 175, 749, 10.1086/513967 Schiff, 1985, Challenge with rubella virus after loss of detectable vaccine-induced antibody, Rev. Infect. Dis., 7, S157, 10.1093/clinids/7.Supplement_1.S157 Skendzel, 1996, Rubella immunity: defining the level of protective antibody, Am. J. Clin. Pathol., 106, 170, 10.1093/ajcp/106.2.170 Skendzel, 1992 Best, 1980, Rubella immunity by four different techniques: results of challenge studies, J. Med. Virol., 5, 239, 10.1002/jmv.1890050308 Bouthry, 2016, Assessing immunity to rubella virus: a plea for standardization of IgG (Immuno)assays, J. Clin. Microbiol., 54, 1720, 10.1128/JCM.00383-16 Dimech, 1992, Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter, J. Clin. Microbiol., 30, 633, 10.1128/JCM.30.3.633-641.1992 Dimech, 2008, Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter, J. Clin. Microbiol., 46, 1955, 10.1128/JCM.00231-08 James, 2006, Rubella dilemma: are patients being immunized unnecessarily?, J. Clin. Virol., 36, S33, 10.1016/S1386-6532(06)80821-8 Dimech, 2013, Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays, Clin. Vaccine Immunol., 20, 255, 10.1128/CVI.00603-12 Dimech, 2016, Standardization of assays that detect anti-Rubella virus IgG antibodies, Clin. Microbiol. Rev., 29, 163, 10.1128/CMR.00045-15 Enders, 2013, Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status, Clin. Vaccine Immunol., 20, 420, 10.1128/CVI.00688-12 Huzly, 2016, Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results, J. Clin. Virol., 74, 13, 10.1016/j.jcv.2015.11.022 Weissfeld, 1982, Comparison of several test systems used for determination of rubella immune status, J. Clin. Microbiol., 16, 82, 10.1128/JCM.16.1.82-85.1982 Shekarchi, 1981, Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus, J. Clin. Microbiol., 13, 850, 10.1128/JCM.13.5.850-854.1981 Wittenburg, 1985, Comparative evaluation of commercial rubella virus antibody kits, J. Clin. Microbiol., 21, 161, 10.1128/JCM.21.2.161-163.1985 Picone O, Bouthry E, Y B-O, Cordier AG, Nedellec S, A L, et al. Determination of Rubella Virus-Specific Humoral and Cell-Mediated Immunity in pregnant women with negative or equivocal Rubella-specific IgG. submitted. Hutton, 2014, Rubella monitoring in pregnancy as a means for evaluating a possible reemergence of rubella, Am. J. Obstet. Gynecol., 211, e1, 10.1016/j.ajog.2014.05.046 Miller, 1990, Rubella reinfection, Arch. Dis. Child., 65, 820, 10.1136/adc.65.8.820 O'Shea, 1994, Rubella reinfection; role of neutralising antibodies and cell-mediated immunity, Clin. Diagn. Virol., 2, 349, 10.1016/0928-0197(94)90005-1 Cusi, 1990, Serological evidence of reinfection among vaccinees during rubella outbreak, Lancet, 336, 1071, 10.1016/0140-6736(90)92545-S Morgan-Capner, 1988, Serological distinction between primary rubella and reinfection, Lancet, 1, 1397, 10.1016/S0140-6736(88)92209-X Braun, 1994, Congenital rubella syndrome despite repeated vaccination of the mother: a coincidence of vaccine failure with failure to vaccinate, Acta Paediatr., 83, 674, 10.1111/j.1651-2227.1994.tb13111.x Gilbert, 1989, Fetal infection after maternal reinfection with rubella, BMJ, 299, 1217, 10.1136/bmj.299.6709.1217-b Hornstein, 1988, Clinical rubella with virus transmission to the fetus in a pregnant woman considered to be immune, N. Engl. J. Med., 319, 1415, 10.1056/NEJM198811243192113 Partridge, 1981, Congenital rubella affecting an infant whose mother had rubella antibodies before conception, Br. Med. J. (Clin. Res. Ed.), 282, 187, 10.1136/bmj.282.6259.187 Forsgren, 1985, Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus to the fetus, Scand. J. Infect. Dis., 17, 337 Weber, 1993, Congenital rubella syndrome after maternal reinfection, Infection, 21, 118, 10.1007/BF01710747 O’Shea, 1983, Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus, J. Infect. Dis., 148, 639, 10.1093/infdis/148.4.639 Schluederberg, 1978, Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals, J. Infect. Dis., 138, 877, 10.1093/infdis/138.6.877 Davidkin, 2004, Epidemiology of rubella in Finland, Euro Surveill., 9, 13, 10.2807/esm.09.04.00459-en Kakoulidou, 2010, Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programs, Vaccine, 28, 1002, 10.1016/j.vaccine.2009.10.130 Papania, 2014, Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience, JAMA Pediatr., 168, 148, 10.1001/jamapediatrics.2013.4342 Plotkin, 2010, Correlates of protection induced by vaccination, Clin. Vaccine Immunol., 17, 1055, 10.1128/CVI.00131-10 Charlton, 2016, How to determine protective immunity in the post-vaccine era, Hum. Vaccine Immunother., 12, 903, 10.1080/21645515.2015.1128600 Wilson, 2006, Humoral immune response to primary rubella virus infection, Clin. Vaccine Immunol., 13, 380, 10.1128/CVI.13.3.380-386.2006 Nedeljkovic, 1999, Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells, J. Clin. Virol., 14, 119, 10.1016/S1386-6532(99)00048-7 Cusi, 1988, Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine, Arch. Virol., 101, 25, 10.1007/BF01314649 Cusi, 1989, Immune responses to wild and vaccine rubella viruses after rubella vaccination, Arch. Virol., 106, 63, 10.1007/BF01311038 Bottiger, 1997, Maturation of rubella IgG avidity over time after acute rubella infection, Clin. Diagn. Virol., 8, 105, 10.1016/S0928-0197(97)00018-4 Nedeljkovic, 2001, Maturation of IgG avidity to individual rubella virus structural proteins, J. Clin. Virol., 22, 47, 10.1016/S1386-6532(01)00161-5 Mauracher, 1993, Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome, J. Immunol., 151, 2041, 10.4049/jimmunol.151.4.2041 Hyde, 2015, Identification of serologic markers for school-Aged children with congenital rubella syndrome, J. Infect. Dis., 212, 57, 10.1093/infdis/jiu604 Byrne, 2012, Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004–2009. Is rubella susceptibility increasing?, Vaccine, 30, 161, 10.1016/j.vaccine.2011.11.045 Forrest, 2003, A resurgence of congenital rubella in Australia?, Commun. Dis. Intell. Q. Rep., 27, 533 Francis, 2006, Factors associated with low immunity to rubella infection on antenatal screening, Aust. N. Z. J. Obstet. Gynaecol., 46, 172, 10.1111/j.1479-828X.2006.00553.x Francis, 2003, The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia, Am. J. Public Health, 93, 1274, 10.2105/AJPH.93.8.1274 Reef, 2002, The changing epidemiology of rubella in the 1990: on the verge of elimination and new challenges for control and prevention, JAMA, 287, 464, 10.1001/jama.287.4.464 Snell, 2017, Screening for potential susceptibility to rubella in an antenatal population: a multivariate analysis, J. Med. Virol., 89, 1532, 10.1002/jmv.24818 Sullivan, 1999, The epidemiology of rubella and congenital rubella in Australia, 1992–1997, Commun. Dis. Intell., 23, 209 Vilajeliu, 2015, Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain, Vaccine, 33, 1767, 10.1016/j.vaccine.2015.02.043 Davidkin, 2008, Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up, J. Infect. Dis., 197, 950, 10.1086/528993 Gilbert, 2017, Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011, Vaccine, 35, 3050, 10.1016/j.vaccine.2017.04.057 Lai, 2015, Determining rubella immunity in pregnant Alberta women 2009–2012, Vaccine, 33, 635, 10.1016/j.vaccine.2014.12.022 LeBaron, 2009, Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine, J. Infect. Dis., 200, 888, 10.1086/605410 Francis, 1982, Rubella screening and vaccination programme at a Melbourne maternity hospital: a five-year review, Med. J. Aust., 1, 502, 10.5694/j.1326-5377.1982.tb124143.x Buimovici-Klein, 1985, Cell-mediated immune response in rubella infections, Rev. Infect. Dis., 7, S123, 10.1093/clinids/7.Supplement_1.S123 Chaye, 1992, Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C, J. Clin. Microbiol., 30, 2323, 10.1128/JCM.30.9.2323-2329.1992 Jokinen, 2007, Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination, J. Infect. Dis., 196, 861, 10.1086/521029 Buimovici-Klein, 1980, Low level rubella immunity detected by ELISA and specific lymphocyte transformation, Arch. Virol., 66, 321, 10.1007/BF01320628 Vaananen, 1986, Effect of low level immunity on response to live rubella virus vaccine, Vaccine, 4, 5, 10.1016/0264-410X(86)90090-3 Wolf, 1993, Symptomatic rubella reinfection in an immune contact of a rubella vaccine recipient, South. Med. J., 86, 91, 10.1097/00007611-199301000-00017 Robinson, 1982, Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized, J. Pediatr., 101, 188, 10.1016/S0022-3476(82)80114-5 Serdula, 1984, Serological response to rubella revaccination, JAMA, 251, 1974, 10.1001/jama.1984.03340390028023 Amanna, 2007, Duration of humoral immunity to common viral and vaccine antigens, N. Engl. J. Med., 357, 1903, 10.1056/NEJMoa066092